180 related articles for article (PubMed ID: 38130311)
21. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
[TBL] [Abstract][Full Text] [Related]
22. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
[TBL] [Abstract][Full Text] [Related]
23. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
Xie W; Xi P; Liu Y; Zhang Z; Sun T
Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
[No Abstract] [Full Text] [Related]
25. Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.
Qiu J; Yang T; Sun Y; Sun K; Xu Y; Xia Q
Oncol Res; 2024; 32(3):545-561. PubMed ID: 38361759
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma.
Ding J; Zhao S; Chen X; Luo C; Peng J; Zhu J; Shen Y; Luo Z; Chen J
Front Genet; 2022; 13():835355. PubMed ID: 35480320
[No Abstract] [Full Text] [Related]
27.
Jiao Y; Li Y; Fu Z; Hou L; Chen Q; Cai Y; Jiang P; He M; Yang Z
Dis Markers; 2019; 2019():9037131. PubMed ID: 31781311
[TBL] [Abstract][Full Text] [Related]
28. Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma.
Zhu T; Wang T; Feng Z; Gao F; Zhang J; Jin C; Tian H; Xu J; Chen H; Ou Q; Wang J; Xu G; Lu L
Front Oncol; 2022; 12():880100. PubMed ID: 35860559
[TBL] [Abstract][Full Text] [Related]
29. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value and immunological role of the small mother against decapentaplegic proteins in kidney renal clear cell carcinoma.
Zhang S; Liu Z; Xiao M; Liu H
Transl Cancer Res; 2021 Jun; 10(6):2678-2693. PubMed ID: 35116580
[TBL] [Abstract][Full Text] [Related]
31. A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma.
Dong P; Zhao L; Zhao L; Zhang J; Lu G; Zhang H; Ma M
Transl Cancer Res; 2024 Jan; 13(1):249-267. PubMed ID: 38410237
[TBL] [Abstract][Full Text] [Related]
32. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
33. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
[TBL] [Abstract][Full Text] [Related]
34. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
Front Immunol; 2022; 13():934387. PubMed ID: 35958561
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of
Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
[No Abstract] [Full Text] [Related]
36. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
37.
Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
[TBL] [Abstract][Full Text] [Related]
38. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
Front Genet; 2023; 14():1109991. PubMed ID: 36992705
[No Abstract] [Full Text] [Related]
39. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration.
Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G
Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]